journal article·2012-11

The effect of grain size on the biocompatibility, cell–materials interface, and mechanical properties of microwave‐sintered bioceramics

Djordje Veljović, Miodrag Čolić, Vesna Kojić, Gordana Bogdanović, Zvezdana Kojić, Andrijana Banjac, Eriks Palcevskis, Rada Petrović, Djordje Janaćković

Publisher page

Abstract

Abstract The effect of decreasing the grain size on the biocompatibility, cell–material interface, and mechanical properties of microwave‐sintered monophase hydroxyapatite bioceramics was investigated in this study. A nanosized stoichiometric hydroxyapatite powder was isostatically pressed at high pressure and sintered in a microwave furnace in order to obtain fine grained dense bioceramics. The samples sintered at 1200°C, with a density near the theoretical one, were composed of micron‐sized grains, while the grain size decreased to 130 nm on decreasing the sintering temperature to 900°C. This decrease in the grain size certainly led to increases in the fracture toughness by much as 54%. An in vitro investigation of biocompatibility with L929 and human MRC‐5 fibroblast cells showed noncytotoxic effects for both types of bioceramics, while the relative cell proliferation rate, cell attachment and metabolic activity of the fibroblasts were improved with decreasing of grain size. An initial in vivo investigation of biocompatibility by the primary cutaneous irritation test showed that both materials exhibited no irritation properties. © 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 100A:3059–3070, 2012.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Dental materials and restorations

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (52)

Show source-provided references
1. 10.1142/9789814317351_000910.1142/9789814317351_0009 ↗
2. 10.1111/j.1151-2916.1991.tb07132.x10.1111/j.1151-2916.1991.tb07132.x ↗
3. 10.1016/j.jeurceramsoc.2008.08.02510.1016/j.jeurceramsoc.2008.08.025 ↗
4. 10.1023/A:100897581279310.1023/A:1008975812793 ↗
5. 10.1016/S0142-9612(01)00219-810.1016/S0142-9612(01)00219-8 ↗
6. 10.1016/j.ceramint.2008.07.00710.1016/j.ceramint.2008.07.007 ↗
7. 10.1002/jbm.a.3305410.1002/jbm.a.33054 ↗
8. 10.1111/j.1151-2916.1998.tb02540.x10.1111/j.1151-2916.1998.tb02540.x ↗
9. 10.1023/A:101853821232810.1023/A:1018538212328 ↗
10. 10.4028/www.scientific.net/KEM.330-332.25910.4028/www.scientific.net/KEM.330-332.259 ↗
11. 10.1016/S0142-9612(01)00076-X10.1016/S0142-9612(01)00076-X ↗
12. 10.1016/j.jeurceramsoc.2010.09.00610.1016/j.jeurceramsoc.2010.09.006 ↗
13. 10.1016/j.actamat.2005.01.03910.1016/j.actamat.2005.01.039 ↗
14. 10.1016/j.ceramint.2010.09.01410.1016/j.ceramint.2010.09.014 ↗
15. 10.1016/j.msec.2008.05.00910.1016/j.msec.2008.05.009 ↗
16. 10.1557/JMR.1994.018010.1557/JMR.1994.0180 ↗
17. 10.1016/S0167-577X(02)00622-510.1016/S0167-577X(02)00622-5 ↗
18. 10.1007/s10853-010-4324-810.1007/s10853-010-4324-8 ↗
19. 10.1016/j.ceramint.2009.09.03810.1016/j.ceramint.2009.09.038 ↗
20. Mayo MJ · 1997 · 361
21. Chiang YM · 1997 · 477
22. 10.1016/j.ceramint.2008.11.02810.1016/j.ceramint.2008.11.028 ↗
23. 10.1016/j.biomaterials.2009.08.04810.1016/j.biomaterials.2009.08.048 ↗
24. 10.1023/A:101992010520710.1023/A:1019920105207 ↗
25. 10.1007/s10856-007-3204-510.1007/s10856-007-3204-5 ↗
26. 10.1002/(SICI)1097-4636(19990315)44:4<407::AID-JBM6>3.0.CO;2-T10.1002/(SICI)1097-4636(19990315)44:4<407::AID-JBM6>3.0.CO;2-T ↗
27. 10.1166/jnn.2002.11610.1166/jnn.2002.116 ↗
28. 10.1016/j.actbio.2010.03.01610.1016/j.actbio.2010.03.016 ↗
29. 10.1016/j.tsf.2011.01.01110.1016/j.tsf.2011.01.011 ↗
30. 10.1002/jbm.b.3190610.1002/jbm.b.31906 ↗
31. 10.1023/B:JMSM.0000021102.68509.6510.1023/B:JMSM.0000021102.68509.65 ↗
32. 10.1016/S0142-9612(00)00121-610.1016/S0142-9612(00)00121-6 ↗
33. 10.1016/S0142-9612(99)00242-210.1016/S0142-9612(99)00242-2 ↗
34. 10.1002/jemt.111610.1002/jemt.1116 ↗
35. 10.1016/j.actbio.2009.06.02710.1016/j.actbio.2009.06.027 ↗
36. The irritative property of alpha tricalcium phosphate to the rabbit skin
37. 10.1007/PL0002032810.1007/PL00020328 ↗
38. Granulated composite powders on basis of hydroxyapatite and plasma‐processed zirconia and alumina nanopowders
39. 10.1111/j.1151-2916.1976.tb10991.x10.1111/j.1151-2916.1976.tb10991.x ↗
40. 10.1007/BF0321490410.1007/BF03214904 ↗
41. In vitro assays for antitumor‐drug screening on human tumor cell lines: Dye exclusion test and colorimetric cytotoxicity assays
42. 10.1016/0022-1759(83)90303-410.1016/0022-1759(83)90303-4 ↗
43. 10.1016/S0272-8842(01)00102-X10.1016/S0272-8842(01)00102-X ↗
44. 10.1016/S0142-9612(01)00220-410.1016/S0142-9612(01)00220-4 ↗
45. 10.1016/j.biomaterials.2003.09.08810.1016/j.biomaterials.2003.09.088 ↗
46. 10.1007/s10856-007-3347-410.1007/s10856-007-3347-4 ↗
47. 10.1016/j.actbio.2008.07.03510.1016/j.actbio.2008.07.035 ↗
48. 10.1016/j.archoralbio.2008.01.00910.1016/j.archoralbio.2008.01.009 ↗
49. 10.1088/1757-899X/23/1/01203210.1088/1757-899X/23/1/012032 ↗
50. Bone cell attachment to dental implants of different surface characteristics
51. 10.1016/j.jmbbm.2010.06.00310.1016/j.jmbbm.2010.06.003 ↗
52. 10.1007/s10856-009-3939-210.1007/s10856-009-3939-2 ↗